Holtkamp M - Search Results

1

An aCGH classifier derived from BRCA1-mutated breast cancer and benefit of high-dose platinum-based chemotherapy in HER2-negative breast cancer patients.

Vollebergh MA, Lips EH, Nederlof PM, Wessels LFA, Schmidt MK, van Beers EH, Cornelissen S, Holtkamp M, Froklage FE, de Vries EGE, Schrama JG, Wesseling J, van de Vijver MJ, van Tinteren H, de Bruin M, Hauptmann M, Rodenhuis S, Linn SC. Vollebergh MA, et al. Among authors: holtkamp m. Ann Oncol. 2011 Jul;22(7):1561-1570. doi: 10.1093/annonc/mdq624. Epub 2010 Dec 6. Ann Oncol. 2011. PMID: 21135055 Free PMC article. Clinical Trial.

2

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size.

van der Wall E, Richel DJ, Holtkamp MJ, Slaper-Cortenbach IC, van der Schoot CE, Dalesio O, Nooijen WJ, Schornagel JH, Rodenhuis S. van der Wall E, et al. Among authors: holtkamp mj. Ann Oncol. 1994 Nov;5(9):795-802. doi: 10.1093/oxfordjournals.annonc.a059007. Ann Oncol. 1994. PMID: 7531486 Free article.

3

High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.

van der Wall E, Nooijen WJ, Baars JW, Holtkamp MJ, Schorangel JH, Richel DJ, Rutgers EJ, Slaper-Cortenbach IC, van der Schoot CE, Rodenhuis S. van der Wall E, et al. Among authors: holtkamp mj. Br J Cancer. 1995 Apr;71(4):857-62. doi: 10.1038/bjc.1995.165. Br J Cancer. 1995. PMID: 7536025 Free PMC article. Clinical Trial.

4

Feasibility of multiple courses of high-dose cyclophosphamide, thiotepa, and carboplatin for breast cancer or germ cell cancer.

Rodenhuis S, Westermann A, Holtkamp MJ, Nooijen WJ, Baars JW, van der Wall E, Slaper-Cortenbach IC, Schornagel JH. Rodenhuis S, et al. Among authors: holtkamp mj. J Clin Oncol. 1996 May;14(5):1473-83. doi: 10.1200/JCO.1996.14.5.1473. J Clin Oncol. 1996. PMID: 8622061 Clinical Trial.

5

Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.

van der Wall E, Rutgers EJ, Holtkamp MJ, Baars JW, Schornagel JH, Peterse JL, Beijnen JH, Rodenhuis S. van der Wall E, et al. Among authors: holtkamp mj. Br J Cancer. 1996 May;73(9):1080-5. doi: 10.1038/bjc.1996.208. Br J Cancer. 1996. PMID: 8624267 Free PMC article. Clinical Trial.

6

Mobilisation of blood progenitor cells with ifosfamide and etoposide (VP-16) in combination with recombinant human G-CSF (Filgrastim) in patients with malignant lymphomas or solid tumours.

Baars JW, Holtkamp MJ, Nooyen WJ, Walll EV, Te Velde A, Dalesio O, Slaper-Cortenbach IC, Schoot EV, Richel DJ, Gerritsen WR, Schornagel JH, Rodenhuis S. Baars JW, et al. Among authors: holtkamp mj. Anticancer Res. 1996 Sep-Oct;16(5B):3089-95. Anticancer Res. 1996. PMID: 8920773

7

Sampling technique from central venous catheters proves critical for pharmacokinetic studies.

Huitema AD, Holtkamp M, Tibben MM, Rodenhuis S, Beijnen JH. Huitema AD, et al. Among authors: holtkamp m. Ther Drug Monit. 1999 Feb;21(1):102-4. doi: 10.1097/00007691-199902000-00016. Ther Drug Monit. 1999. PMID: 10051062

8

Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.

Schrama JG, Baars JW, Holtkamp MJ, Schornagel JH, Beijnen JH, Rodenhuis S. Schrama JG, et al. Among authors: holtkamp mj. Bone Marrow Transplant. 2001 Jul;28(2):173-80. doi: 10.1038/sj.bmt.1703105. Bone Marrow Transplant. 2001. PMID: 11509935 Clinical Trial.

9

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin.

Huitema AD, Spaander M, Mathĵt RA, Tibben MM, Holtkamp MJ, Beijnen JH, Rodenhuis S. Huitema AD, et al. Among authors: holtkamp mj. Ann Oncol. 2002 Mar;13(3):374-84. doi: 10.1093/annonc/mdf052. Ann Oncol. 2002. PMID: 11996467 Free article.

10

Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience.

Schrama JG, Holtkamp MJ, Baars JW, Schornagel JH, Rodenhuis S. Schrama JG, et al. Among authors: holtkamp mj. Br J Cancer. 2003 Jun 16;88(12):1831-8. doi: 10.1038/sj.bjc.6601001. Br J Cancer. 2003. PMID: 12799623 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

210 results

Search Page